Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study in Healthy Volunteers and Diabetes Mellitus Type II Subjects to Determine the Safety, Pharmacokinetics and Pharmacodynamics Profile of Insulin Injected by the MicronJet Device

NCT00602914 is registered in ClinicalTrials.gov with NanoPass Technologies Ltd as lead sponsor.

NCT NCT00602914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00602914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study in Healthy Volunteers and Diabetes Mellitus Type II Subjects to Determine the Safety, Pharmacokinetics and Pharmacodynamics Profile of Insulin Injected by the MicronJet Device
Lead sponsor
NanoPass Technologies Ltd
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2008
Completion date
July 31, 2009
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intradermal injections